Gene: Fam149a (family with sequence similarity 149, member A)
Rattus norvegicus |
| Symbol: |
Fam149a
|
| Name: |
family with sequence similarity 149, member A
|
| Description: |
INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; ammonium chloride; rosiglitazone |
| Type: |
protein-coding
|
| RefSeq Status: |
MODEL
|
| Also known as: |
family with sequence similarity 149, member A; hypothetical LOC361153; hypothetical loc361153; LOC361153; loc361153
|
| Orthologs: |
Homo sapiens : FAM149A
(family with sequence similarity 149, member A)
HGNC
Mus musculus : Fam149a
(family with sequence similarity 149, member A)
MGI
|
| Latest Assembly: |
RGSC Genome Assembly v3.4
|
| Position: |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 16 | q11 | | NCBI | RGSC Genome Assembly v5.0 | 16 | 49,773,192 - 49,829,726 | + | NCBI | RGSC Genome Assembly v3.4 | 16 | 50,146,296 - 50,202,278 | + | NCBI | Rat Celera Assembly | 16 | 44,846,656 - 44,903,969 | + | NCBI |
|
| Model |
|
|
 Gene-Chemical Interaction Annotations
References - curated Genomics
Comparative Map Data
| Fam149a (Rattus norvegicus) |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 16 | q11 | | NCBI | RGSC Genome Assembly v5.0 | 16 | 49,773,192 - 49,829,726 | + | NCBI | RGSC Genome Assembly v3.4 | 16 | 50,146,296 - 50,202,278 | + | NCBI | Rat Celera Assembly | 16 | 44,846,656 - 44,903,969 | + | NCBI |
|
| FAM149A (Homo sapiens) |
| Map | Chr | Position | Strand | Source |
|---|
Human Alternate Assembly CHM1_1 | 4 | 186,824,943 - 186,852,366 | + | NCBI | Human Genome Assembly HuRef | 4 | 182,817,905 - 182,845,396 | + | NCBI | Human Genome Assembly GRCh37 | 4 | 187,065,995 - 187,093,817 | + | NCBI | Human Celera Assembly | 4 | 184,388,532 - 184,416,266 | + | NCBI | Human Genome Assembly Build 36 | 4 | 187,302,989 - 187,330,811 | + | NCBI | Human Cytogenetic Map | 4 | q35.1 | | NCBI |
|
| Fam149a (Mus musculus) |
| Map | Chr | Position | Strand | Source |
|---|
Mouse Genome Assembly GRCm38 | 8 | 45,336,715 - 45,382,291 | - | NCBI | Mouse cM Map | 8 | | - | NCBI | Mouse Celera Assembly | 8 | 48,024,168 - 48,069,370 | - | NCBI | Mouse Genome Assembly Build 37 | 8 | 46,422,069 - 46,467,645 | - | NCBI | Mouse Genome Assembly Build 36.1 | 8 | 46,422,069 - 46,467,645 | - | NCBI | Mouse Cytogenetic Map | 8 | B1.1 | | NCBI |
|
Position Markers
| RH129178 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 16 | q11 | | UniSTS | RGSC Genome Assembly v5.0 | 16 | 49,828,096 - 49,828,289 | | UniSTS | RGSC Genome Assembly v3.4 | 16 | 50,202,022 - 50,202,215 | | UniSTS | Rat Celera Assembly | 16 | 44,902,339 - 44,902,532 | | UniSTS | RH 3.4 | 16 | 460.9 | | UniSTS |
|
| RH144010 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 16 | q11 | | UniSTS | RGSC Genome Assembly v5.0 | 16 | 49,813,397 - 49,813,611 | | UniSTS | RGSC Genome Assembly v3.4 | 16 | 50,187,442 - 50,187,656 | | UniSTS | Rat Celera Assembly | 16 | 44,887,640 - 44,887,854 | | UniSTS | RH 3.4 | 16 | 462.1 | | UniSTS |
|
| AW530202 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 16 | q11 | | UniSTS | RGSC Genome Assembly v5.0 | 16 | 49,810,439 - 49,810,618 | | UniSTS | RGSC Genome Assembly v3.4 | 16 | 50,184,484 - 50,184,663 | | UniSTS | Rat Celera Assembly | 16 | 44,884,682 - 44,884,861 | | UniSTS | RH 3.4 | 16 | 460.69 | | UniSTS |
|
QTLs in Region (RGSC Genome Assembly v3.4)
| 1600378 | Arunc4 | Aerobic running capacity QTL 4 | | .03 | Aerobic running capacity | best distance run to exhaustion | 16 | 350121 | 85734479 | Rat | | 2312660 | Bw95 | Body weight QTL 95 | | .05 | Body weight | adiposity index | 16 | 819225 | 63306215 | Rat | | 2312663 | Slep9 | Serum leptin concentration QTL 9 | | .001 | Hormone level | leptin | 16 | 819225 | 63306215 | Rat | | 2312666 | Insul16 | Insulin level QTL 16 | | .01 | Insulin level | serum | 16 | 819225 | 63306215 | Rat | | 2312669 | Stl23 | Serum triglyceride level QTL 23 | | .01 | Lipid level | triglyceride | 16 | 819225 | 63306215 | Rat | | 737819 | Hcas4 | Hepatocarcinoma susceptibility QTL 4 | 4.43 | | Liver tumor susceptibility | nodule number | 16 | 4304396 | 50266190 | Rat | | 61405 | Niddm6 | Non-insulin dependent diabetes mellitus QTL 6 | 3.66 | .001 | Glucose level | | 16 | 4304396 | 52304351 | Rat | | 737826 | Alc11 | Alcohol consumption QTL 11 | 3.2 | | Consumption level | alcohol preference | 16 | 4304396 | 64081533 | Rat | | 70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.2 | | Gastric tumor resistance | tumor invasions depth | 16 | 18121291 | 70196694 | Rat | | 70215 | Niddm29 | Non-insulin dependent diabetes mellitus QTL 29 | 3.54 | | Glucose level | postprandial | 16 | 19510772 | 80047126 | Rat | | 2302057 | Pia29 | Pristane induced arthritis QTL 29 | 3.6 | .001 | Joint/bone inflammation | pristane induced | 16 | 24934312 | 69934312 | Rat | | 6903294 | Stl30 | Serum triglyceride level QTL 30 | 2.6 | .0013 | Lipid level | triglyceride level | 16 | 28455247 | 73455247 | Rat | | 1298529 | Arunc1 | Aerobic running capacity QTL 1 | 4 | | Aerobic running capacity | | 16 | 35339929 | 63977788 | Rat | | 1578768 | Stresp22 | Stress response QTL 22 | 2.8 | | Stress response | thymus weight | 16 | 39026337 | 84026337 | Rat | | 2293690 | Bss45 | Bone structure and strength QTL 45 | 5.13 | .0001 | Bone structure | | 16 | 41581459 | 86581459 | Rat | | 2300163 | Bmd64 | Bone mineral density QTL 64 | 5.3 | .0001 | Bone mineral density | | 16 | 41581459 | 86581459 | Rat | | 631833 | Sach2 | Saccharin preference QTL 2 | 2.5 | .02 | Consumption level | saccharin preference | 16 | 46137355 | 53486191 | Rat | | 7205510 | Activ5 | Activity QTL 5 | 3.78 | .00028 | Activity level | Locomotor activity | 16 | 46718586 | 90238779 | Rat | |
